Literature DB >> 77714

Rh isoimmunization during pregnancy: antenatal prophylaxis.

J M Bowman, B Chown, M Lewis, J M Pollock.   

Abstract

Of 3533 Rh-negative women who began a pregnancy without detectable Rh antibodies, 62 (1.8%) demonstrated evidence of Rh isoimmunization during pregnancy or within 3 days after delivery. All denied transfusions as well as abortions or previous pregnancies not followed by the administration of Rh immune globulin. Rh isoimmunization during pregnancy or within 3 days after delivery, which will not be prevented by the administration of Rh immune globulin after delivery, is the most important cause of residual Rh isoimmunization. A clinical trial of antenatal administration of Rh immune globulin, initially at 34 weeks's and subsequently at 28 and 34 weeks' gestation, in 1357 Rh-negative pregnant women who were delivered of Rh-positive babies, was effective in preventing the development of Rh isoimmunization during pregnancy or within 3 days after delivery. Antenatal prophylaxis with Rh immune globulin will be necessary if the incidence of Rh isoimmunization is to be reduced to its lowest possible level. Antenatal prophylaxis at 28 weeks' gestation is now an insured service in Manitoba.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77714      PMCID: PMC1818025     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  [Demonstration of fetal hemoglobin in erythrocytes of a blood smear].

Authors:  E KLEIHAUER; H BRAUN; K BETKE
Journal:  Klin Wochenschr       Date:  1957-06-15

2.  The slanted capillary method of rhesus blood-grouping.

Authors:  B CHOWN; M LEWIS
Journal:  J Clin Pathol       Date:  1951-11       Impact factor: 3.411

  2 in total
  21 in total

Review 1.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  Incidence of rhesus immunisation after genetic amniocentesis.

Authors:  A Tabor; D Jerne; J E Bock
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

3.  Eradication of Rh hemolytic disease of the newborn.

Authors:  J G Kelton
Journal:  Can Med Assoc J       Date:  1980-12-06       Impact factor: 8.262

Review 4.  The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.

Authors:  Giancarlo Maria Liumbruno; Angelo D'Alessandro; Federica Rea; Vanessa Piccinini; Liviana Catalano; Gabriele Calizzani; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

Review 5.  Anti-D prophylaxis in 1997: the Edinburgh Consensus Statement.

Authors:  D James
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

6.  Pump up the volume? The routine early use of colloid in very preterm infants.

Authors:  P Hope
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

7.  Preventing Rh haemolytic disease.

Authors: 
Journal:  Br Med J       Date:  1978-07-29

8.  Compliance with postpartum Rh isoimmunization prophylaxis in Alberta.

Authors:  S Huchcroft; P Gunton; T Bowen
Journal:  CMAJ       Date:  1985-11-01       Impact factor: 8.262

9.  Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen.

Authors:  Jeanne E Hendrickson; Eldad A Hod; Steven L Spitalnik; Christopher D Hillyer; James C Zimring
Journal:  Transfusion       Date:  2009-11-09       Impact factor: 3.157

10.  WinRho: Rh immune globulin prepared by ion exchange for intravenous use.

Authors:  J M Bowman; A D Friesen; J M Pollock; W E Taylor
Journal:  Can Med Assoc J       Date:  1980-12-06       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.